- Home
- VSTE vs ETON Comparison
VSTE vs ETON Comparison
Compare VSTE & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- ETON
- Stock Information
- Founded
- VSTE 2009
- ETON 2017
- Country
- VSTE Australia
- ETON United States
- Employees
- VSTE N/A
- ETON N/A
- Industry
- VSTE
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- ETON Health Care
- Exchange
- VSTE Nasdaq
- ETON Nasdaq
- Market Cap
- VSTE 30.0M
- ETON 199.5M
- IPO Year
- VSTE N/A
- ETON 2018
- Fundamental
- Price
- VSTE $2.42
- ETON $8.77
- Analyst Decision
- VSTE
- ETON Strong Buy
- Analyst Count
- VSTE 0
- ETON 3
- Target Price
- VSTE N/A
- ETON $12.00
- AVG Volume (30 Days)
- VSTE 14.1K
- ETON 214.1K
- Earning Date
- VSTE 01-01-0001
- ETON 11-11-2024
- Dividend Yield
- VSTE N/A
- ETON N/A
- EPS Growth
- VSTE N/A
- ETON N/A
- EPS
- VSTE N/A
- ETON N/A
- Revenue
- VSTE $342,000.00
- ETON $31,381,000.00
- Revenue This Year
- VSTE N/A
- ETON $19.61
- Revenue Next Year
- VSTE N/A
- ETON $35.39
- P/E Ratio
- VSTE N/A
- ETON N/A
- Revenue Growth
- VSTE N/A
- ETON 8.14
- 52 Week Low
- VSTE $0.83
- ETON $3.03
- 52 Week High
- VSTE $12.00
- ETON $8.66
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- ETON 76.07
- Support Level
- VSTE $0.83
- ETON $7.58
- Resistance Level
- VSTE $1.09
- ETON $8.66
- Average True Range (ATR)
- VSTE 0.10
- ETON 0.42
- MACD
- VSTE 0.03
- ETON -0.07
- Stochastic Oscillator
- VSTE 92.08
- ETON 91.49
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.